| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/18/2007 | US20070014763 Pegylated g-csf polypeptides and methods of producing same |
| 01/18/2007 | US20070014762 Pegylated g-csf polypeptides and methods of producing same |
| 01/18/2007 | US20070014761 Heterodimeric four helix bundle cytokines |
| 01/18/2007 | US20070014759 Glycopegylated granulocyte colony stimulating factor |
| 01/18/2007 | US20070014747 Novel peptidic conjugates for alopecia preventive and curative treatment |
| 01/18/2007 | US20070014742 A mixture of polypeptides, as calcium binding protein for reducing bone loss and reducing renal phosphate excretion; biodrug for treating bone disorders; injectable solution or dispersed in toothpaste or a mouthwash; drug delivery gum patch |
| 01/18/2007 | US20070014725 Conjugates of macrocyclic metal complexes with biomolecules and their use for the production of agents for NMR diagnosis and radiodiagnosis as well as radiotherapy |
| 01/18/2007 | DE102005033250A1 Verfahren zur Reinigung von G-CSF A method for purifying G-CSF |
| 01/18/2007 | DE10019075B4 Verwendung von CD34 oder einem davon abgeleiteten Polypeptid als Zell-Oberflächen- bzw. Gentransfer-Marker Use of CD34 or a polypeptide derived as a cell-surface markers or gene transfer |
| 01/18/2007 | CA2793119A1 Melanocortin receptor ligands |
| 01/18/2007 | CA2625061A1 Novel bacterial proteins with pesticidal activity |
| 01/18/2007 | CA2617559A1 Variant iaspp polypeptide and screening assay |
| 01/18/2007 | CA2615025A1 A method for detecting peptides comprising a cross-.beta. structure |
| 01/18/2007 | CA2614941A1 Method for detecting peptides comprising a cross-beta structure |
| 01/18/2007 | CA2614680A1 Il-32 modulators |
| 01/18/2007 | CA2614186A1 Il-6 binding proteins |
| 01/18/2007 | CA2613970A1 Chimeric vaccine for haemophilus influenzae-induced disease |
| 01/18/2007 | CA2613619A1 Sp1 polypeptides, modified sp1 polypeptides and uses thereof |
| 01/18/2007 | CA2610830A1 Egfr inhibitors promote axon regeneration |
| 01/18/2007 | CA2510657A1 Polypeptides with an activity in the mtbe degradation pathway and their use |
| 01/17/2007 | EP1743941A1 Novel mite allergen |
| 01/17/2007 | EP1743940A1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide |
| 01/17/2007 | EP1743904A2 Guinea pig chymase |
| 01/17/2007 | EP1743903A2 Methods and compositions for treating disorders involving excitotoxicity |
| 01/17/2007 | EP1743653A1 Composition for increasing body height |
| 01/17/2007 | EP1743652A1 Vaccine for respiratory and reproductive system infections in cattle |
| 01/17/2007 | EP1743650A2 Feline intrerferon against feline atopic dermatitis |
| 01/17/2007 | EP1743648A1 Method for treating inflammation |
| 01/17/2007 | EP1743176A1 Method for the detection of a neurological or psychiatric, demential disease, especially alzheimer's disease by use of cholecystokinin (cck)-molecules, corresponding substances and detection reagents |
| 01/17/2007 | EP1743040A2 Hdm2-inhibitor complexes and uses thereof |
| 01/17/2007 | EP1743034A2 Peptide substrates recognisable by a botulinum toxin a, bont/a and the use thereof |
| 01/17/2007 | EP1743027A1 Mutant pneumolysin proteins |
| 01/17/2007 | EP1742971A2 N-acylated chitinous polymers and methods of use thereof |
| 01/17/2007 | EP1742968A2 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 01/17/2007 | EP1742965A2 Treatments for pancreatic cancer |
| 01/17/2007 | EP1742964A2 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation |
| 01/17/2007 | EP1742963A2 Synthesis and purification of west nile virus virus-like particles |
| 01/17/2007 | EP1742708A2 Identification of antigenically important neisseria antigens by screening insertional mutant libraries with antiserum |
| 01/17/2007 | EP1742658A2 Cellular permissivity factor for viruses, and uses thereof |
| 01/17/2007 | EP1742657A2 Immunization regimen with e4-deleted adenovirus prime and e1-deleted adenovirus boost |
| 01/17/2007 | EP1742653A2 Ammonium/ammonia transporter |
| 01/17/2007 | EP1654379A4 Methods and compositions for enhanced protein expression and purification |
| 01/17/2007 | EP1546717A4 Analyzing nerve cell damage |
| 01/17/2007 | EP1540010A4 Use of biomarkers for detecting ovarian cancer |
| 01/17/2007 | EP1399480B1 Multimers of class i major histocompatibility complexes containing modified beta2-microglobulin proteins |
| 01/17/2007 | EP1368474B1 Polynucleotide useful for modulating cancer cell proliferation |
| 01/17/2007 | EP1349945B1 Method for the production of a heterologous protein by a fungus |
| 01/17/2007 | EP1335646B1 Transgenic or recombinant non-human mammals for stop protein and their uses in screening psycho-active medicines |
| 01/17/2007 | EP1301539B1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/17/2007 | EP1268783B9 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 01/17/2007 | EP1263783B1 Maurocalcine, analogues thereof and their therapeutical uses |
| 01/17/2007 | EP1228232B1 Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
| 01/17/2007 | EP1223977B1 Modified plant viruses and methods of use thereof |
| 01/17/2007 | EP1179539B1 Protein having hemolytic activity and gene encoding the protein |
| 01/17/2007 | EP1140174B1 Antagonist antibodies of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 01/17/2007 | EP1131430B1 Mitogenic regulators |
| 01/17/2007 | EP1087996B1 Glycosulfopeptides and methods of synthesis and use thereof |
| 01/17/2007 | EP1086207B1 Novel methods and interferon deficient substrates for the propagation of viruses |
| 01/17/2007 | EP1076704B1 Il-2 selective agonists and antagonists |
| 01/17/2007 | EP0986312B1 Method for treating a lactic raw material containing gmp |
| 01/17/2007 | EP0959689B1 Frozen confectionery products |
| 01/17/2007 | EP0954588B1 Ob fusion protein compositions and methods |
| 01/17/2007 | EP0762901B9 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING |
| 01/17/2007 | EP0687272B1 Method and compositions for recombinant osteogenic protein production |
| 01/17/2007 | EP0220273B2 Synthetic antigens for the detection of aids-related disease |
| 01/17/2007 | CN1898563A Method of diagnosing breast cancer |
| 01/17/2007 | CN1898392A Process for preparing l-amino acids using strains of the enterobacteriaceae family |
| 01/17/2007 | CN1898390A Promoters for expression in modified vaccinia virus ankara |
| 01/17/2007 | CN1898388A Pgro expression units |
| 01/17/2007 | CN1898385A Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof |
| 01/17/2007 | CN1898384A Msp-3-like family of genes |
| 01/17/2007 | CN1898263A Nucleic acid encoding a novel prostaglandin receptor protein and methods of use thereof |
| 01/17/2007 | CN1898262A Il-7 fusion proteins |
| 01/17/2007 | CN1898261A Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof |
| 01/17/2007 | CN1898260A Peptides with anti-obesity activity and other related uses |
| 01/17/2007 | CN1898259A Gene variants coding for proteins from the metabolic pathway of fine chemicals |
| 01/17/2007 | CN1897977A In vivo gene therapy of parkinson's disease |
| 01/17/2007 | CN1897965A Method of treating or preventing biological or immunological responses to a reactive chemical or biological or toxic agent |
| 01/17/2007 | CN1897959A Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions |
| 01/17/2007 | CN1897951A Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 01/17/2007 | CN1896241A Enteromycin C2 total gene, its clone and heterologous expression |
| 01/17/2007 | CN1896239A Production of recombinant human serum albumin with rice-embryo milk cell as biological reactor |
| 01/17/2007 | CN1896237A Human g protein-coupled orphan receptors |
| 01/17/2007 | CN1896106A Preparation of human plasma protein fused long-effective interferon |
| 01/17/2007 | CN1896105A Compounds and methods of early diagnosis of cervical cancer and genital condyloma with hpv, chsp60 tumor suppressor h-ras, k-ras and pten derived peptides modified |
| 01/17/2007 | CN1896103A N-terminally monopegylated polypeptides and process for their preparation |
| 01/17/2007 | CN1896101A Use of anticholinergic M3-type receptor antibody determination for diagonsing sicca syndrome |
| 01/17/2007 | CN1896100A Liver regenerated factor and its use |
| 01/17/2007 | CN1896099A Zinc finger binding domains for gnn |
| 01/17/2007 | CN1896098A Buthotoxin polypeptide and its use |
| 01/17/2007 | CN1896097A Peptide for promoting insulin release of frog and its use in production of drugs |
| 01/17/2007 | CN1896096A Production of high-activity extrasin beta 4 derivative by gene engineering |
| 01/17/2007 | CN1896095A Lucid ganoderma sugar peptide, its production and use |
| 01/17/2007 | CN1895670A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
| 01/17/2007 | CN1895660A Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 01/17/2007 | CN1295334C Wheat anti-disease related gene TaEDR1 and its application |
| 01/17/2007 | CN1295332C Recombinant human alkaline fiber forming cell growth factor gene and its nonfusion expression product, production method and application |
| 01/17/2007 | CN1295331C Oncogene, recombinant protein derived therefrom, and uses thereof |
| 01/17/2007 | CN1295248C Small salt mustard sodium hydrogen pump protein gene TNHX1 and its anti salt application |
| 01/17/2007 | CN1295247C Ganoderma lucidum polysaccharide protein and its preparing method and use |